---
title: Charles River Laboratories vs Syngene International
slug_a: criver
slug_b: syngeneintl
site: cro
review_signal_gate: closed
canonical_path: /compare/criver/syngeneintl
generated_by: BioBM Editorial AI
---

# Charles River Laboratories vs Syngene International

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Charles River Laboratories (criver) is listed for both. Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.

Services: 21. Modalities: 6. Indications: 3. Locations: 7. Certifications: 5. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (21).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Syngene International (syngeneintl) is listed for both. Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

Services: 100. Modalities: 10. Indications: 14. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (100).

Review summary: Review summary withheld until site-level review gate opens.